Advertisement

Topics

PAREXEL’s Alberto Grignolo Named Fellow by Drug Information Association

07:30 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Honored for contributing to the advancement of health care PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, Ph.D., Corporate Vice ...

Other Sources for this Article

Media:
Dana Robie
Tel.: +1 781-434-4772
Email: Dana.Robie@PAREXEL.com
or
Kathryn McMahon, PAN Communications
Tel: +1 617-502-4300
Email: PAREXEL@pancomm.com
or
Investors:
Ronald Aldridge
Tel.: +1-781-434-4753
Email: ron.aldridge@PAREXEL.com

NEXT ARTICLE

More From BioPortfolio on "PAREXEL’s Alberto Grignolo Named Fellow by Drug Information Association"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...